Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

Weak linkage at 4p16 to predisposition for human neuroblastoma

Abstract

The most frequent genetic alterations described in neuroblastoma (NB) are amplification of MYCN oncogene and deletion of chromosome 1p, although somatic deletions have been demonstrated at other chromosomal intervals. Since loss of heterozygosity (LOH) at distal 4p has been observed in about 20–29% of neuroblastomas, we have evaluated deletions in 41 Italian NB samples by LOH analysis at loci mapping to 4p as follows: pter-D4S2936-D4S412-D4S2957-D4S432-D4S3023-D4S431-cen. Our analysis showed allele losses in eight out of 41 samples (19.5%) and allowed the identification of a smallest region of overlapping deletion (SRO) of 3.0 cM, delimited by D4S412 and D4S3023. Two of these tumors with 4p LOH are from patients belonging to a family with recurrent NB. Interestingly the genotyping of this family revealed an identical haplotype that includes the nonrecombinant loci D4S412, D4S2957 and D4S432 shared by all affected children and demonstrated that this haplotype is retained in the two tumors carrying somatic deletions from patients of this family. Furthermore linkage analysis was performed in two NB families and yielded an overall lod-score of 3.0 in the interval including the haplotype. This provides a confirmatory indication that the region delimited by D4S2936 and D4S3023, which also includes the new defined SRO, may harbor NB predisposing gene/s.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Altura RA, Maris JM, Li H, Boyett JM, Brodeur GM, Look AT . 1997 Genes Chromosomes Cancer 19: 176–184

  • Bown N, Lastowska M, Cotterill S, O'Neill S, Ellershaw C, Roberts P, Lewis I, Pearson AD . 2001 Med. Pediatr. Oncol. 36: 14–19

  • Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM . 1984 Science 224: 1121–1124

  • Caron H, van Sluis P, Buschman R, Pereira do Tanque R, Maes P, Beks L, de Kraker J, Voute PA, Vergnaud G, Westerveld A, Slater R, Versteeg R . 1996 Hum. Genet. 97: 834–837

  • Knudson Jr AG . 1971 Proc. Natl. Acad. Sci. USA 68: 820–823

  • Knudson AG, Strong LC . 1972 Am. J. Hum. Genet. 24: 514–532

  • Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES . 1996 Am. J. Hum. Genet. 58: 1347–1363

  • Lo Cunsolo C, Bicocchi MP, Petti AR, Tonini GP . 2000 Br. J. Cancer 83: 1295–1300

  • Martinsson T, Sjöberg RM, Hedborg F, Hallstenson K, Nordling M, Kogner P . 1997 Eur. J. Cancer 33: 1997–2001

  • O'Connell JR, Weeks DE . 1995 Nat. Genet. 11: 402–408

  • Oude Luttikhuis ME, Powell JE, Rees SA, Genus T, Chughtai S, Ramani P, Mann JR, McConville CM . 2001 Br. J. Cancer 85: 531–537

  • Perri P, Pession A, Mazzocco M, Scaruffi P, Strigini P, Iolascon A, Albergoni MP, Basso G, Tonini GP . 1997 Eur. J. Cancer 33: 1949–1952

  • Schwab M, Varmus HE, Bishop JM, Grzeschik KH, Naylor SL, Sakaguchi AY, Brodeur G, Trent J . 1984 Nature 308: 288–291

  • Schwab M, Praml C, Amler LC . 1996 Genes Chromosomes Cancer 16: 211–229

  • Srivatsan ES, Ying KL, Seeger RC . 1993 Genes Chromosomes Cancer 7: 32–37

  • Takita J, Hayashi Y, Kohno T, Shiseki M, Yamaguchi N, Hanada R, Yamamoto K, Yokota J . 1995 Oncogene 11: 1829–1834

  • Vandesompele J, Van Roy N, Van Gele M, Laureys G, Ambros P, Heimann P, Devalck C, Schuuring E, Brock P, Otten J, Gyselinck J, De Paepe A, Speleman F . 1998 Genes Chromosomes Cancer 23: 141–152

  • Vandesompele J, Speleman F, Van Roy N, Laureys G, Brinkschmidt C, Christiansen H, Lampert F, Lastowska M, Bown N, Pearson A, Nicholson JC, Ross F, Combaret V, Delattre O, Feuerstein BG, Plantaz D . 2001 Med. Pediatr. Oncol. 36: 5–10

  • Weiss WA, Aldape K, Mohapatra G, Feuerstein BG, Bishop JM . 1997 EMBO J. 16: 2985–2995

  • White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hillard C, Valentine MB, Look AT, Enomoto H, Sakiyama S, Brodeur GM . 1995 Proc. Natl. Acad. Sci. USA 92: 5520–5524

Download references

Acknowledgements

This work was supported by Fondazione Italiana per la Lotta al Neuroblastoma. We are grateful to surgeons, clinicians and pathologists of the Italian Cooperative Group for Neuroblastoma and AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) supplying tumor samples and clinical data, to Dr Katia Mazzocco for MYCN amplification and 1p deletion data and to Dr Roberta Bricchetto for language revision.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gian Paolo Tonini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perri, P., Longo, L., Cusano, R. et al. Weak linkage at 4p16 to predisposition for human neuroblastoma. Oncogene 21, 8356–8360 (2002). https://doi.org/10.1038/sj.onc.1206009

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206009

Keywords

This article is cited by

Search

Quick links